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Abstract
Background: Including qualitative evidence on patients’ perspectives in systematic reviews of complex
interventions may reveal reasons for variation in trial findings. This is particularly the case when the intervention is
for a long-term disease, as management may rely heavily on the efforts of the patient. Inclusion though seldom
happens, possibly because of methodological challenges, and when it does occur the different forms of evidence
are often kept separate. To explore heterogeneity in trial findings, we tested a novel approach to integrate
qualitative review evidence on patients’ perspectives with evidence from a Cochrane systematic review.
Methods: We used, as a framework for a matrix, evidence from a qualitative review on patients’ perspectives on
helping them manage their disease. We then logged in the matrix whether the interventions identified in a
Cochrane review corresponded with the patient perspectives on how to help them. We then explored
correspondence.
The Cochrane review we used included 19 trials of interventions to improve adherence to therapy in HIV/AIDS
patients. The qualitative review we used included 23 studies on HIV/AIDS patients’ perspectives on adherence; it
translated the themes identified across the studies into recommendations in how to help patients adhere.
Both reviews assessed quality. In the qualitative review they found no difference in findings between the better
quality studies and the weaker ones. In the Cochrane review they were unable to explore the impact of quality in
subgroup analysis because so few studies were of good quality.
Results: Matrix tabulation of interventions and patients’ perspectives identified a range of priorities raised by
people infected with HIV-1 that were not addressed in evaluated interventions. Tabulation of the more robust trials
revealed that interventions that significantly improved adherence contained more components considered
important by patients than interventions where no statistically significant effect was found.
Conclusions: This simple approach breaks new ground in cross tabulating qualitative evidence with the
characteristics of trialled interventions. In doing so it tests the assumption that patients are more likely to adhere to
interventions that match more closely with their concerns. The potential of this approach in exploring varying
content and rates of success in trialled complex interventions deserves further evaluation.
Background
Complex multi-component healthcare interventions are
challenging to evaluate [1]; variation between trials in
the nature of an intervention and its effect can make it
difficult to derive conclusions in systematic reviews
[2,3]. The Cochrane handbook for systematic reviews
acknowledges that inclusion of evidence on patients’
perspectives can potentially reveal reasons for trial varia-
tion in effect [4]. Such insight, which is commonly
derived from qualitative research, may inform the devel-
opment of more appropriate interventions. This may
particularly be the case for interventions for a long-term
condition, where management can rely heavily on the
patient as a co-producer of health [5]. Including such
evidence with evidence on effectiveness rarely occurs.
This is possibly because of the considerable methodolo-
gical challenges involved [6,7]. As there are so few
worked examples, a researcher attempting to do so is
forced to make subjective decisions that will affect the
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outcome of the project. These include how the qualita-
tive evidence is collected and analysed, and how it is
used with the trial evidence.
In the worked examples available the different forms
of evidence are often not brought together in analysis
[8]. Instead they are reported in separate papers, where
any integration of their findings is reserved for the dis-
cussion section. However, combining analytically the dif-
ferent types of data has the potential to reveal more
about the relationship between the different forms of
evidence. A realist synthesis does this by using other
evidence to help explain the success or failure of a com-
plex intervention, such as the theories or mechanisms
postulated by the trial’s authors or that are generated
from other sources including patients [9]. However this
approach, described as ‘a logic of enquiry’ [10, p 32]
rather than a method, lacks transparency, thereby
departing from the more explicit and staged approaches
to reduce bias, which have distinguished and helped
legitimise systematic review methods [11].
We used a contrasting approach, which conforms
more to the conventions of systematic reviewing. It
uses the existing primary research on a topic that
meets certain criteria. It is also explicit in how it
assesses and analyses the evidence. The approach
explores mixed data correspondence, by tabulating in a
matrix the findings of difference sources of evidence.
This way of mixing the data has been used by other
researchers to combine two reviews; one on patient
perspectives and one on effectiveness [12]. The
researchers used two-by-two matrices to link the find-
ings from qualitative studies about children’s perspec-
tives on healthy eating with trial evidence on the
effectiveness of an intervention to promote healthy eat-
ing in children. Population of the matrix represented
whether there was correspondence between the two
sources of data. The matrices provided an explanation
for how components of the intervention contributed to
its effect; for instance, interventions that increased
vegetable consumption the most were those that came
closest to children ’s views by not focusing on the
health benefits, or conflating fruit and vegetables.
Constructing an evidence matrix that goes beyond
four categories (i.e. two-by-two matrices) is undertaken
in Qualitative Comparative Analysis (QCA) [13]. It is
the first stage in data analysis, which then proceeds, if
sufficient data are available, by using algorithmic logic
to identify differences in data correspondence relative to
the outcome of interest. By including more evidence the
matrices as they are used in QCA can explore more of
the relationships between the data. This approach has
been used in public health topics, for instance in explor-
ing across countries socio-economic factors relating to
suicide and traffic injury [14]. We are not aware that
this way of combining data has been used to explore
complex healthcare interventions.
In this study we took all evidence from a qualitative
review of patient’s perspectives on helping them manage
their disease and logged in matrices the degree to which
interventions identified in a complementary Cochrane
review corresponded with those perspectives.
Method
Data sources and selection criteria
The study used data from two published systematic
reviews; one a Cochrane review on the effectiveness of
an intervention, the other a qualitative review on
patients’ perspectives. We selected the two reviews for
this study based on five criteria. The first two were on
the appropriateness of the topic: (1) the disease in ques-
tion required long-term self-management, and (2) the
reviews’ research questions closely complemented each
other in disease topic. The second two were on the
appropriateness of the findings: (3) the effectiveness
review evaluated an intervention promoting patient self-
management, identified relevant trials, and the findings
of the individual trials varied in size of effect, and (4)
the qualitative review analysed evidence on patients’ per-
spectives by considering how they may contribute to
appropriateness of therapies. The fifth criterion was that
both reviews needed to report procedures to minimise
bias in their findings. Specifically for the Cochrane
review we required that they only included randomised
controlled trials, and the quality of the trials included
was taken into account in their findings. For the qualita-
tive review, that they assessed quality using criteria com-
monly included in appraisal tools, such as those
included in Critical Appraisal Skills Programme for qua-
litative studies [15]. Such criteria could include whether
measures existed to assure validity of data collection,
and that data analyses were sufficiently rigorous. We
also assessed the methodological quality of the qualita-
tive and the Cochrane review. Methods and reporting
standards for undertaking a review of qualitative studies
are under-developed; therefore methodological quality
was assessed for both reviews using the AMSTAR [16]
measurement tool to assess the methodological quality
of systematic reviews. This 11-item tool includes ques-
tions on whether the review processes were undertaken
in duplicate, whether the characteristics of the included
studies were included, and whether the scientific quality
of the included studies was assessed and documented.
This tool has not been specifically designed for reviews
that include qualitative evidence; therefore we also fol-
lowed guidelines on how to assess quality in qualitative
primary research [15,17,18]. These included assessing
the validity of data by triangulation, whether methods
were clear on data collection and that the findings are
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relevant in that they can be generalised beyond settings
in which they were generated.
Complementary reviews in HIV/AIDS
From searches in the Cochrane library and in Medline a
complementary pair of reviews was identified that
matched our inclusion criteria [19,20]. One review com-
bined evidence from qualitative studies on what is
known from the perspectives of HIV/AIDS patients
about the problems associated with adhering to highly
active antiretroviral therapy (HAART) [20]. The review
identified 23 eligible studies, giving a combined total
sample of 916 participants. The review authors’ quality
assessment found half the studies were rated as poor
quality but, given their findings were in most respects
comparable with the findings of the other studies, they
were not excluded. The review authors describe the ana-
lysis of the studies as proceeding by ‘reading the publi-
cation several times during which the findings were
coded inductively in thematic groups and compared’.
Thirteen primary themes were identified from the 23
studies and all themes, apart from one on homelessness,
were identified in at least 7 studies. In their discussion
of their findings the reviewers translated the themes
into recommendations for promoting adherence. To
help distinguish the type of recommendations they were
grouped by WHO classification of risk factors influen-
cing adherence to long-term therapies, namely relating
to therapy, disease status i.e. having HIV-1, patient fac-
tors such as motivation to take therapy, healthcare team
and system, and socio-economic circumstances [21].
The Cochrane systematic review evaluated the effec-
tiveness of support and education strategies in improv-
ing HIV/AIDS patients’ adherence to HAART [19]. This
review included 19 randomised controlled trials (RCTs)
giving a total sample of 2,159 participants. The
reviewers did not combine trial data in a meta-analysis
because of heterogeneity in population, intervention,
and outcome assessment. They describe the populations
across the trials as heterogeneous; specifically while
most evaluated the intervention in a mixed general
population others focused on high-risk groups, or parti-
cular populations such as women, children or an ethnic
minority group. However, likewise there were differ-
ences in the study populations evaluated in the qualita-
tive review. Whilst, all interventions were directed at the
patient, and all were support and education-based inter-
ventions intended to improve adherence to HAART,
they differed in content. A few involved cognitive man-
agement strategies, and one intervention indirectly tar-
geted adherence by aiming to reduce risky sexual
behaviours. Outcome assessment differed in how adher-
ence was measured including, for example, pharmacy
refill and self-report of the number of missed doses. The
Cochrane reviewers found ten interventions were effec-
tive in increasing adherence to the prescribed medica-
tion; these were delivered to individuals rather than in
groups, included six out of the seven interventions pro-
vided over 12 weeks, and six out of the eight interven-
tions that aimed to improve practical medication skills
such as by using memory aids. The reviewers used eight
criteria to assess the validity of the trials findings and
provided reasons for selection of the criteria based on
design issues specific to adherence enhancing interven-
tion studies [22] and the Consort Statement [23]. The
criteria were: details on randomisation, concealment of
allocation, an objective measure of adherence, interven-
tion and control patients receiving similar trial contact
time, follow-up for six months or longer, attrition of
20% of less in both trial arms at the end of the interven-
tion and at six months follow-up, and that the data from
all participants were analysed. Overall, the trials were
reported as methodologically weak. The median criteria
fulfilled were two out of a possible eight; three trials ful-
filled none of the criteria. There were two distinct clus-
ters of trials; a few fulfilling at least half of the eight
criteria, and the majority fulfilling none or few criteria.
As the reviewers were unable to undertake meta-analysis
they could not explore in sensitivity analysis the impact
of trial quality on their findings.
Data extracted from qualitative review
We first extracted from the qualitative reviews’ discus-
sion section the recommendations for promoting adher-
ence from the qualitative review. These we listed as 21
recommendations (Appendix 1). In accordance with the
authors of the qualitative review we grouped the recom-
mendations by the WHO classification of risk factors
influencing adherence to long-term therapy [21].
Extraction and coding of data from Cochrane review
We extracted data, from the Cochrane review, on the
effectiveness of the interventions. Given that the trials
measured adherence in various ways we could not stan-
dardise trial findings for the purposes of comparison.
Instead we extracted data on whether the intervention
was found to improve adherence significantly. One trial
was excluded as it did not provide a between trial group
comparison of the benefit of the intervention [24].
We planned to extract descriptions of the trialled inter-
ventions from the Cochrane review but, as the review
only provided limited details on their composition, we
sought this information from the original published
papers reporting the trials findings. This information was
central to our analysis, so we set additional inclusion cri-
teria. Firstly, that at least a paragraph in the methods sec-
tion of the paper was dedicated to describing the
intervention content. Two trials were subsequently
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excluded [25,26]. We assessed the remaining 16 trial
papers’ descriptions of their interventions according to
guidelines from the extension of the CONSORT state-
ment to trials of non-pharmacologic treatment [27]. Spe-
cifically, we found all trial papers provided a description
of different components of the interventions, but two did
not report that the intervention was tailored to the indi-
vidual and so were excluded [28,29].
Review of the 14 remaining trials revealed that all inter-
ventions aimed to improve medication management
skills; this involved various techniques, for example,
adaptation of dose schedules according to participants’
risk factors and/or provision of adherence gadgets such
as timers [30-43]. Apart from one where the comparative
trial arm involved additional medication monitoring [39],
all the interventions were compared with usual care. For
each trial we extracted, as appropriate, the details of the
intervention on to a standardised data sheet listing the 21
recommendations derived from the qualitative review.
We only entered data on the trialled intervention for
matches identified between components and recommen-
dations. For example, an intervention in one trial fulfilled
the recommendation ’Healthcare providers should
acquire and use insight into possible factors influencing
each individual patient before starting treatment’ because
it was described as ‘In the first visit the nurse determines
the specific problems that exist with respect to knowledge
and understanding of HIV infection and current antire-
troviral medication adherence’. We assessed each corre-
spondence between the trial intervention components on
whether it was a full or, if appropriate to the recommen-
dation, a partial match. For example, a partial match
would be reported if for the recommendation ’Clear
information should be given on side effects how to manage
side effect, including those that may be unpleasant and
distressing’, the trial authors reported that side effects
were discussed but did not report that they provided
information on how to manage them.
Initially, one reviewer extracted the trial data. This
extraction was checked independently by two additional
observers, who, although not disagreeing with the
matches identified, found a small number that were
missed by the other. Therefore, a further independent
data extraction was undertaken by a layperson masked
to the findings of the trial. Each time a passage describ-
ing the intervention matched a recommendation the lay-
person underlined and marked it with which
recommendation it matched. This transparent method
of data matching allowed us to confirm that we had not
missed any matches in the unmarked text.
Matrix for configuring and comparing the data
We used the data sheet extractions to build a matrix.
Each column represented a recommendation for an
intervention component derived from the qualitative
review, while each row represented whether an indivi-
dual trial’s intervention matched any of the recommen-
dations. We marked a cell ‘X’ when a commonality (a
correspondence) was found between a patient recom-
mendation and an intervention component. It was
marked ‘x’ if only a partial correspondence was identi-
fied. It was left blank when the intervention content did
not correspond with a patient-based recommendation.
The final cell, per trial row, indicated whether or not
the intervention was found to be effective. We used the
WHO classification of risk factors influencing adherence
to long-term therapy [21] as a framework to group the
links found between the interventions and the recom-
mendations. See Table 1.
We built two matrices. Many of the trials in the
Cochrane review were methodologically weak. Therefore
in our first matrix we used as a cut-off to explore het-
erogeneity of effect the cluster of four trials that fulfilled
at least half of the set quality criteria. We explored
visually whether there were differences in configura-
tional matches in the mixed review data between the
two successful interventions and the two that had no
effect. In the second matrix we entered the data extrac-
tions for all trials to explore how well the patient
recommendations were reflected in the components of
the evaluated interventions.
Results
The two higher quality trials in which the intervention
significantly improved adherence addressed a wider
range of barriers and facilitators that patients felt were
important to adherence than the two higher quality
trials where the intervention did not improve adherence.
These latter trials did not address three types of barriers
and facilitators; namely, general and overarching factors,
those relating to HIV-1 status, and those relating to
social circumstances (Table 1). The effective interven-
tions both matched two recommendations that the inef-
fective interventions did not; specifically ’To get patients
to describe their own behaviour so as to pick up any
risky patterns’ and ’To develop a trusting relationship
with the patient’. There were also two recommendations
that the effective trials either matched or partially
matched and where no match was identified in the
interventions found not to improve adherence. These
were: ’To enquire for each patient before starting the
treatment into the possible factors influencing adherence’
and ‘Regular discussion of the details of circumstances
that lead to forgetting medication can reveal aspects that
need attention to improve adherence e.g. capacity to
organise life and activities, and to anticipate risky situa-
tions’. Nevertheless, there was one recommendation that
was matched in the ineffective interventions that was
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not matched in the effective interventions, namely ’Clear
information should be given on how to manage side
effects, including those that may be unpleasant and
distressing’.
When we brought together in the second matrix the
data extraction sheets for all 14 trials, we found few
trials had included recommendations relating to HIV-1
status, or for personal social circumstances (Table 2).
This included, for example, the recommendations
derived from the qualitative review that ’Secrecy is threa-
tened by taking treatment, therefore the possibility of dis-
closure should be discussed as openness leads to higher
adherence. If disclosure is not an option, the patient can
be advised how to take medication in secret to avoid
skipping doses’ and ’To acquire insight into a patient’s
social support systems, and counsel the patient on how
to use such support’.
Discussion
We used a simple approach to explore whether qualita-
tive review evidence can explain the findings of a sys-
tematic review of effectiveness of a complex
intervention. The approach breaks new ground by com-
paring in a matrix data derived from a qualitative review
with data from a quantitative systematic review. By
tabulating these two forms of data we were able to
explore how patients’ views matched the various compo-
nents of trialled interventions.
Table 1 Tabulation of the four higher quality trials
Recommendations (1-21) for interventions drawn from qualitative review on patient’s perspectives [20]sub-divided
by WHO type of adherence risk factor [21]and if Cochrane review [19]found trialled intervention increased
adherence (Y, N)
General over
arching
(1-3)
Therapy
(4-6)
HIV-1
status
(7, 8)
Patient
(9-14)
Healthcare
(15-18)
Social circumstances
(19-21)
Trialled interventions 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Berrien 2004 X X X X X X X X Y
Pradier 2003 x X x X x X X x x X X X Y
Rathburn 2005 X x X x N
Rawlings 2003 x X X X N
’X’ = correspondence between the patient recommendation and the content of the intervention, ‘x’ = the content of the intervention partially corresponded with the
recommendation.
Table 2 Tabulation of all trials
Recommendations (1-21) for interventions drawn from qualitative review on patient’s perspectives [20]sub-divided
by WHO type of adherence risk factor [21]
General over
arching
(1-3)
Therapy
(4-6)
HIV-1
status
(7, 8)
Patient
(9-14)
Healthcare
(15-18)
Social circumstances
(19-21)
Trialled interventions 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Berrien 2004 X X X X X X X X
Dilorio 2003 x
Fairley 2003 X X X x x X
Goujard 2003 x x X
Levy 2004 X X x x X
Murphy 2002 X X x x
Pradier 2003 x X x X x x X x x X X X
Rathburn 2005 X x x x
Rawlings 2003 x X X X
Safren 2001 x x x x X
Safren 2003 X X
Samet 2005 X X X x X X x X x X
Smith 2003 X x X X X x X X
Tulda 2000 x x X x X X x
’X’ = correspondence between the patient recommendation and the content of the intervention,’x’ = the content of the intervention partially corresponded with the
recommendation.
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The authors of the Cochrane review found that inter-
ventions targeting practical medication management
skills were more often linked to successful adherence
outcomes than those that did not target such skills [19].
By using our approach other information about the
intervention components was revealed. Firstly, successful
interventions contained a broader range of components
that worked on barriers and facilitators to anti-retroviral
drug adherence considered important by people infected
with HIV-1. This finding is perhaps of no surprise but
on the other hand this has not, to our knowledge, been
formally explored before. What is surprising is that not
all types of priorities raised by patients had been fully
evaluated in the interventions included in the most
recent update of the Cochrane review.
Limitations
In this study any conclusions drawn on the differences
between evaluated interventions are tentative as none of
the trials was without risk of biased findings. Further-
more, conclusions cannot be drawn on which compo-
nents are essential or superfluous, or on whether the
recommendations not taken up in the reviewed trials
would have any impact on adherence if included in
further trials. The reason for bringing quantitative trial
data together with qualitative evidence on patients’
views is not to demonstrate a causal link; rather it is
hypothesis generating by providing possible explanations
for variation between trial findings.
Incomplete reporting in trial reports poses a threat to
the validity of this approach, which is dependent on the
quality of information provided on the interventions.
We did attempt to ask for further information with the
authors where an email address was provided. The
approach was abandoned, as few responded and not all
who responded provided information. However, to
reduce the risk of incomplete reporting we only
included trials that devoted a paragraph or more in
their methods section to describing the intervention and
which fulfilled the extension of the CONSORT State-
ment to trials of non-pharmacologic treatment on
reporting of intervention content [27]. It could also be
argued that while trial authors may not report all
aspects of an intervention in the paper publishing their
findings, they are likely to report the major components.
While this has not been tested, a study of 80 papers
describing evaluations of complex interventions found
that the most common aspect missing from descriptions
of treatments was detail on intervention process as
opposed to content, such as timing of treatments [44].
Another limitation in this approach is our subjective
evaluation of matches between the qualitative studies
and the trials. However, to reduce this potential bias the
matches identified were checked several times. Although
neither of the first two checks disagreed with what had
been extracted in the first extraction, each identified
matches that were missed. The third check was an inde-
pendent data extraction by a layperson who was masked
to the trial findings. The transparent method of data
matching in this final check minimised the likelihood
that any further matches were missed. Finally, we were
reliant on the skills of the researchers of the two pub-
lished reviewers we used. To reduce this limitation we
only selected reviews of a high standard.
Implications
Systematic reviews select and combine all high quality
randomised trials of a given intervention. They provide
the highest quality evidence on effectiveness of a treat-
ment or service. The approach presented here aims, by
providing more evidence on intervention components, to
increase the potential learning from a systematic review
of a complex intervention. This information could lead to
the development of more appropriate interventions.
There are a growing number of approaches for com-
bining evidence from different types of studies. Practical
experience and worked examples of different approaches
are limited. This paper adds to this literature. However,
it is uncertain how many other health topics would be
suitable for the approach demonstrated in this paper,
particularly as qualitative syntheses remain relatively
uncommon and methods for qualitative synthesis vary
across a range of dimensions [45]. The qualitative review
we used in this study used a thematic synthesis
approach [46]. Specifically, it aimed to identify all avail-
able data and to assess the quality of the studies
included. The analysis involved coding of the findings of
primary studies and the organisation of these ‘free
codes’ into themes. Other researchers have explored
whether a meta-ethnography of qualitative studies could
potentially inform a Cochrane review on the effective-
ness of interventions to promote adherence to tubercu-
losis treatment. Meta-ethnography was not developed as
a method of systematic review but rather as a way of
combining individual studies in one analysis. It involves
several stages; a central stage is to translate studies into
one another by in-depth review of key concepts or
themes across studies [47]. One group that used the
findings of meta-ethnography with evidence from a
Cochrane review on adherence to tuberculosis therapy
reported difficulties in translating their qualitative synth-
esis into recommendations for interventions. They sug-
gested that meta-ethnography is more suitable for
generating models or higher order theories of behaviour
or experiences [48]. We stress however, that where
reviews of studies on patients’ perspectives do not pre-
sent their data as recommendations in relation to a
therapy, then our approach would be difficult.
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The potential of the approach tested here should be
further explored. While the number of reviews of quali-
tative evidence on patients’ perspectives is small, it is
slowly growing. The approach could be used to explore
whether combinations of intervention components
matching patients’ views vary with the trials’ effect sizes.
Statistical analysis of the matrix data may be restricted
because of the limited data points that mixed review evi-
dence could provide but further analysis could explore,
in a review with more methodologically robust trials,
the value of using the algorithmic logic of QCA to
explore variation in trial findings. The potential of QCA
in combining qualitative and qualitative evidence synth-
esis in health care research is recognised by review
methodologists [7] and, while we were unable to explore
its full potential in the study presented here, we are cur-
rently doing so using evidence from a Cochrane sys-
tematic review where there are more trials that can be
combined with qualitative review evidence [49].
Conclusions
Our approach breaks new ground by combining qualitative
and quantitative data in matrices that show whether effec-
tive interventions are more likely to contain components
patients believe are important than ineffective interven-
tions. In short, it directly tests the assumption that patients
are more likely to stick to interventions that contain more
of their concerns. The value of this approach in exploring
heterogeneity in trial content and findings deserves further
evaluation. We encourage authors publishing trial findings
to provide an adequate description of their intervention.
We also call for more reviews of qualitative evidence on
patients’ perspectives and, in particular, qualitative reviews
that complement existing reviews of trials.
Appendix 1: Recommendations for adherence
interventions drawn from the qualitative review
on HIV/AIDS patient’s perspectives*
General and overarching
1. Adherence is a dynamic phenomenon in which
the interplay of a number of influences varies over
time. Therefore ongoing attention to adherence
should have highest priority.
2. To enquire into the possible factors influencing
adherence for each individual patient before starting
treatment.
3. To use insight into the possible adherence factors
influencing each individual patient before starting
treatment.
Therapy related
4. Medication should be adapted to life rather than
life to medication: e.g. the provider should
encourage the use of a watch or pillbox with an
alarm to remind a patient to take medication and to
prevent (unwanted) disclosure.
5. Clear information should be given on side effects
how to manage side effect, including those that may
be unpleasant and distressing.
6. During every visit any ambivalence towards medi-
cations should be discussed.
Condition related
7. Patients’ acceptance of their HIV status should be
discussed on a regular basis, bearing in mind that tak-
ing medication can renew confrontation with diagnosis.
8. Secrecy is threatened by taking treatment. There-
fore the possibility of disclosure should be discussed
as openness leads to higher adherence: if disclosure
is not an option, the patient can be advised how to
take medication in secret to avoid skipping doses.
Patient related
9. Feedback about positive reactions of the body to
treatment should be provided at each visit to pro-
mote adherence e.g. decreased viral load.
10. Pointing out the value of treatment to a patient’s
life enhances motivation.
11. Information transfer appropriate to a patient’s
level of understanding will lead to the patient having
correct knowledge of what constitutes good adher-
ence practice.
12. It is important to get patients to describe their
own behaviour so as to pick up any risky patterns.
13. Regular discussion of the circumstances that lead to
forgetting medication can reveal aspects that need
attention to improve adherence e.g. capacity to organise
life and activities, and to anticipate risky situations.
14. Depression or substance misuse should be mana-
ged as first priority.
Healthcare related
15. To develop a trusting relationship with the patient.
16. To give clear instructions on how to take
medication.
17. To explain the relationship between adherence
and viral load.
18. To offer good medical follow up.
Socio-economic related
19. To acquire insight into a patient’s social support
systems, and counselled the patient on how to use
such support.
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20. Attention to possible negative social circum-
stances e.g. mothers of young children may need
help to fit medication into hectic schedules.
21. Social support has to be substantial and practical.
*Derived from Vervoort review [20]and grouped by
WHO [21]type of adherence risk factor
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